Instrumento Inactivo

Otros idiomas Gracell Biotechnologies Inc.

Acciones

GRCL

US38406L1035

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Global markets live: Booking, Diageo, AT&T, Nvidia, UBS...	23/02
Les arbres ne montent pas jusqu'au ciel (sauf Nvidia)	23/02
En Direct des Marchés : LVMH, Bouygues, Alten, Fnac Darty, Booking, Nvidia, Novo Nordisk, Diageo	23/02
EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"	22/02
AstraZeneca Completes Gracell Biotechnologies Acquisition	22/02
AstraZeneca : finalise l'achat de Gracell Biotechnologies	22/02
AstraZeneca Closes Purchase of Gracell Biotechnologies	22/02
Gracell Biotechnologies Acquisition Completed	22/02
AstraZeneca : finalise le rachat du chinois Gracell	22/02
Gracell Biotechnologies Inc.(NasdaqGS:GRCL) dropped from NASDAQ Composite Index	22/02
AstraZeneca Treasury Limited completed the acquisition of Gracell Biotechnologies Inc. from a group of shareholders.	22/02
Gracell Biotechnologies Announces Shareholders Approval of Merger Agreement	21/02
Gracell Biotechnologies Inc.(NasdaqGS:GRCL) dropped from NASDAQ Biotechnology Index	21/02
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement	20/02
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement	20/02
Astrazeneca: bénéfice 2023 dopé malgré la perte des recettes Covid	08/02
Le bric-à-brac de Zonebourse : Trois records historiques, une galaxie lointaine et du M&A	06/02
Gracell Biotechnologies Cleared for Early-Stage Trial of Prospective Multiple Myeloma Treatment	29/01
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma	29/01
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma	29/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Gracell Biotechnologies Inc.

Acciones

GRCL

US38406L1035

Otros idiomas

Filtros